MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2018 International Congress

    Pilot economic evaluation of Personal KinetiGraph (PKG) for management of Parkinson’s disease in Australia

    P. Lynch, D. Jackson, D. Tilden, M. Horne (Minnetonka, MN, USA)

    Objective: To determine the potential cost savings and quality of life gains with the Personal KinetiGraph (PKG) in the management of patients with Parkinson’s disease…
  • 2018 International Congress

    Influence of dopamine deficiency on interhemispheric crosstalk in Parkinson’s disease

    P. Loehrer, F. Nettersheim, I. Weber, F. Jung, L. Timmermann (Marburg, Germany)

    Objective: To identify the significance of dopaminergic depletion in Parkinson’s disease (PD) on interhemispheric crosstalk using a complex bimanual tapping task. Background: Dopamine deficiency in…
  • 2018 International Congress

    A randomized, double-blind, placebo-controlled Phase II Efficacy and Safety Study of the PDE10A inhibitor PF-02545920 in Huntington Disease (AMARYLLIS)

    M. Delnomdedieu, Y. Tan, A. Ogde, Z. Berger, R. Reilmann (Cambridge, MA, USA)

    Objective: To assess efficacy on motor function, safety and tolerability of the phosphodiesterase-10A inhibitor PF-02545920 in Huntington disease (HD). Conclusion: PF-02545920 was generally safe and…
  • 2018 International Congress

    Costs and outcomes for Parkinson’s disease patients who have their management adjusted by Personal KinetiGraph (PKG)

    P. Lynch, D. Jackson, D. Tilden, M. Horne (Minnetonka, MN, USA)

    Objective: To quantify the potential cost savings and quality adjusted life years (QALYs) gained for people with Parkinson’s disease in Australia whose oral therapy was…
  • 2018 International Congress

    Naturalistic-based UPDRS-III Minimal Clinically Important Difference (MCID) in early PD

    M. Matarazzo, P. Martínez Martín, J.C. Martínez-Ávila, A. Gómez de-la-Cámara, L. Giancardo, T. Arroyo Gallego, P. Montero Escribano, V. Puertas-Martín, I. Obeso, I. Butterworth, C.S. Mendoza, M.J. Catalán, J.A. Molina-Arjona, F. Bermejo-Pareja, J.C. Martínez-Castrillo, L. López-Manzanares, A. Alonso-Canovas, J. Herreros-Rodríguez, M. Gray, Á. Sánchez-Ferro (Vancouver, BC, Canada)

    Objective: To find the MCID of the UPDRS-III subscale in early PD subjects, when started on a new dopaminergic drug. Background: The concept of Minimally…
  • 2018 International Congress

    Speech in Huntington’s Disease

    J.C.S. Chan, A. Vogel, J. Stout (Victoria, Australia)

    Objective: To review existing literature on speech function in Huntington’s disease (HD) across the disease spectrum. Background: Impairment in speech production affects the majority of…
  • 2018 International Congress

    Feasibility of a multi-sensor data fusion method for assessment of Parkinson’s disease motor symptoms

    M. Memedi, S. Aghanavesi, D. Nyholm, F. Bergquist, M. Senek (Örebro, Sweden)

    Objective: To assess the feasibility of measuring Parkinson’s disease (PD) motor symptoms with a multi-sensor data fusion method. More specifically, the aim is to assess…
  • 2018 International Congress

    Neuronal correlates of oculomotor alterations in Huntington’s disease. A 18-FDG PET study

    J. Perez, S. Martinez Horta, F. Sampedro, J. Pagonabarraga, A. Horta, D. Lopez Mora, A. Lozano, V. Camacho, B. Gomez-Anson, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the neuroanatomical correlates of the oculomotor abnormalities in Huntington's disease (HD) through a 18-FDG PET study Background: Alterations of the oculomotor function…
  • 2018 International Congress

    Safety and efficacy of high definition tDCS for proprioception and balance in Parkinson’s disease: A pilot randomised trial

    H. Teasdale, E. Preston, A. Flood, G. Waddington (Canberra, Australia)

    Objective: To determine: 1. Is HD-tDCS safe and well-tolerated in PD? 2. Does combined HD-tDCS and physical exercise improve proprioception and balance in PD? Background:…
  • 2018 International Congress

    Ankle proprioception and postural instability in Parkinson’s disease

    H. Teasdale, E. Preston, W. Spratford, G. Waddington (Bruce, Australia)

    Objective: To determine: 1. Is there a correlation between central and peripheral proprioception in Parkinson’s disease? 2. Does postural instability increase with lack of vision…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley